Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Clinical trial NCT06930807 · RECRUITING

Trial details

NCT number: NCT06930807
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Minimal Residual Disease Adaptive Treatment

Start date: 2025-03-25
Primary completion: 2027-07-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.